What's Happening?
The Broadway revival of 'Every Brilliant Thing,' featuring Daniel Radcliffe, has successfully recouped its $5.75 million capitalization. Producers Second Half Productions, Seaview, and Gavin Kalin Productions announced the financial milestone following
the performance week ending May 3, during which the solo show grossed $1,718,476. The play, written by Duncan Macmillan with Jonny Donahoe and directed by Jeremy Herrin, has been a top-grossing production since its previews began at the Hudson Theatre on February 21, with its official opening on March 12. Recently, the production received Tony Award nominations for Best Revival of a Play and Best Leading Actor in a Play for Radcliffe. The limited engagement is set to extend through June 28, with Mariska Hargitay joining the cast on May 26, while Radcliffe will perform his final show on May 24.
Why It's Important?
The financial success of 'Every Brilliant Thing' highlights the viability and appeal of Broadway revivals, particularly those featuring high-profile actors like Daniel Radcliffe. The recoupment of its capitalization is a significant achievement, reflecting strong audience interest and ticket sales. This success may encourage producers to invest in similar projects, potentially boosting the Broadway economy and providing more opportunities for actors and creatives. Additionally, the Tony nominations could further enhance the play's reputation and draw more audiences, contributing to the cultural vibrancy of Broadway and supporting its recovery post-pandemic.
